A citation-based method for searching scientific literature


List of co-cited articles
50 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
40

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
30

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay,[...]. Br J Cancer 2012
110
30

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Stephanie M Wong, Rachel A Freedman, Yasuaki Sagara, Fatih Aydogan, William T Barry, Mehra Golshan. Ann Surg 2017
168
30

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
Antonis Valachis, Andreas D Nearchou, Pehr Lind. Breast Cancer Res Treat 2014
67
30

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
D Gareth R Evans, Sarah L Ingham, Andrew Baildam, Gary L Ross, Fiona Lalloo, Iain Buchan, Anthony Howell. Breast Cancer Res Treat 2013
93
20

Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Bernadette A M Heemskerk-Gerritsen, Matti A Rookus, Cora M Aalfs, Margreet G E M Ausems, Johanna M Collée, Liesbeth Jansen, C Marleen Kets, Kristien B M I Keymeulen, Linetta B Koppert, Hanne E J Meijers-Heijboer,[...]. Int J Cancer 2015
85
20

ATM, radiation, and the risk of second primary breast cancer.
Jonine L Bernstein, Patrick Concannon. Int J Radiat Biol 2017
22
20


Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
158
20

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Nisreen Elsayegh, Rachel D Webster, Angelica M Gutierrez Barrera, Heather Lin, Henry M Kuerer, Jennifer K Litton, Isabelle Bedrosian, Banu K Arun. Cancer Med 2018
12
20

Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer.
Hongliang Chen, Peng Zhang, Mingdi Zhang, Maoli Wang, Fang Bai, Kejin Wu. J Surg Res 2019
7
28


Surgery for BRCA, TP53 and PALB2: a literature review.
Chin-Vern Song, Soo-Hwang Teo, Nur Aishah Taib, Cheng-Har Yip. Ecancermedicalscience 2018
11
20

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Jessemae L Welsh, Tanya L Hoskin, Courtney N Day, Abigail S Thomas, Jodie A Cogswell, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2017
35
20

Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Nimmi S Kapoor, Lisa D Curcio, Carlee A Blakemore, Amy K Bremner, Rachel E McFarland, John G West, Kimberly C Banks. Ann Surg Oncol 2015
69
20

Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis.
Delal Akdeniz, Marjanka K Schmidt, Caroline M Seynaeve, Danielle McCool, Daniele Giardiello, Alexandra J van den Broek, Michael Hauptmann, Ewout W Steyerberg, Maartje J Hooning. Breast 2019
21
20

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
Pia Vahteristo, Jirina Bartkova, Hannaleena Eerola, Kirsi Syrjäkoski, Salla Ojala, Outi Kilpivaara, Anitta Tamminen, Juha Kononen, Kristiina Aittomäki, Päivi Heikkilä,[...]. Am J Hum Genet 2002
333
20

The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.
Chuan Liu, Ying Wang, Qing-Shui Wang, Ya-Jie Wang. Asian Pac J Cancer Prev 2012
33
20

Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer.
Elzbieta Skasko, Anna Kluska, Anna Niwińska, Ewa Kwiatkowska, Aneta Bałabas, Magdalena Piatkowska, Michalina Dabrowska, Dorota Nowakowska, Tadeusz Pieńkowski. Onkologie 2009
6
33

Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
Pawel Domagala, Dominika Wokolorczyk, Cezary Cybulski, Tomasz Huzarski, Jan Lubinski, Wenancjusz Domagala. Breast Cancer Res Treat 2012
23
20

CHEK2 is a multiorgan cancer susceptibility gene.
C Cybulski, B Górski, T Huzarski, B Masojć, M Mierzejewski, T Debniak, U Teodorczyk, T Byrski, J Gronwald, J Matyjasik,[...]. Am J Hum Genet 2004
316
20

Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.
Petra Kleiblova, Lenka Stolarova, Katerina Krizova, Filip Lhota, Jan Hojny, Petra Zemankova, Ondrej Havranek, Michal Vocka, Marta Cerna, Klara Lhotova,[...]. Int J Cancer 2019
21
20

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kirsi M Kuusisto, Aleksandra Bebel, Mauno Vihinen, Johanna Schleutker, Satu-Leena Sallinen. Breast Cancer Res 2011
76
20

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
483
20

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.
B A M Heemskerk-Gerritsen, M B E Menke-Pluijmers, A Jager, M M A Tilanus-Linthorst, L B Koppert, I M A Obdeijn, C H M van Deurzen, J M Collée, C Seynaeve, M J Hooning. Ann Oncol 2013
64
20

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010
117
20

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
193
20

Risk-reducing mastectomy for the prevention of primary breast cancer.
Nora E Carbine, Liz Lostumbo, Judi Wallace, Henry Ko. Cochrane Database Syst Rev 2018
93
20

Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Amanda K Arrington, Stephanie L Jarosek, Beth A Virnig, Elizabeth B Habermann, Todd M Tuttle. Ann Surg Oncol 2009
178
20

Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.
Krishna Singh, Jenny Lester, Beth Karlan, Catherine Bresee, Tali Geva, Ora Gordon. Am J Obstet Gynecol 2013
39
20

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan,[...]. J Clin Oncol 2004
420
20

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Todd M Tuttle, Elizabeth B Habermann, Erin H Grund, Todd J Morris, Beth A Virnig. J Clin Oncol 2007
459
20

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Shoshana M Rosenberg, Michaela S Tracy, Meghan E Meyer, Karen Sepucha, Shari Gelber, Judi Hirshfield-Bartek, Susan Troyan, Monica Morrow, Lidia Schapira, Steven E Come,[...]. Ann Intern Med 2013
184
20

Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
Judy C Boughey, Deanna J Attai, Steven L Chen, Hiram S Cody, Jill R Dietz, Sheldon M Feldman, Caprice C Greenberg, Rena B Kass, Jeffrey Landercasper, Valerie Lemaine,[...]. Ann Surg Oncol 2016
78
20

Prophylactic mastectomy for the prevention of breast cancer.
Liz Lostumbo, Nora E Carbine, Judi Wallace. Cochrane Database Syst Rev 2010
196
20


Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
344
20

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.
Lori J Pierce, Albert M Levin, Timothy R Rebbeck, Merav A Ben-David, Eitan Friedman, Lawrence J Solin, Eleanor E Harris, David K Gaffney, Bruce G Haffty, Laura A Dawson,[...]. J Clin Oncol 2006
204
20


Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.
Jonine L Bernstein, Duncan C Thomas, Roy E Shore, Mark Robson, John D Boice, Marilyn Stovall, Michael Andersson, Leslie Bernstein, Kathleen E Malone, Anne S Reiner,[...]. Eur J Cancer 2013
43
20

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
502
20

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
178
20

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Youlia M Kirova, Alexia Savignoni, Brigitte Sigal-Zafrani, Anne de La Rochefordiere, Rémy J Salmon, Pascale This, Bernard Asselain, Dominique Stoppa-Lyonnet, Alain Fourquet. Breast Cancer Res Treat 2010
64
20

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
Nadine M Tung, Judy C Boughey, Lori J Pierce, Mark E Robson, Isabelle Bedrosian, Jill R Dietz, Anthony Dragun, Judith Balmana Gelpi, Erin W Hofstatter, Claudine J Isaacs,[...]. J Clin Oncol 2020
66
20

Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view.
Alexis Vallard, Nicolas Magné, Jean-Baptiste Guy, Sophie Espenel, Chloé Rancoule, Peng Diao, Eric Deutsch, Sofia Rivera, Cyrus Chargari. Br J Radiol 2019
11
20

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
328
20

Genetics of breast cancer: a topic in evolution.
S Shiovitz, L A Korde. Ann Oncol 2015
132
20

Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
E Evron, A M Ben-David, H Goldberg, G Fried, B Kaufman, R Catane, M R Pfeffer, D B Geffen, P Chernobelsky, T Karni,[...]. Ann Oncol 2019
24
20

An Analysis of the Decisions Made for Contralateral Prophylactic Mastectomy and Breast Reconstruction.
Patrick J Buchanan, Mariam Abdulghani, Jennifer F Waljee, Jeffrey H Kozlow, Michael S Sabel, Lisa A Newman, Kevin C Chung, Adeyiza O Momoh. Plast Reconstr Surg 2016
32
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.